Dr Susan Hue Swee Shan

Beware of Scam Calls

NUHS Institutions will NEVER ask you to transfer money or disclose bank details over a call.
If in doubt, call the 24/7 ScamShield helpline at 1799, or visit the ScamShield website at www.scamshield.gov.sg.

Doctor Details

2024/01/25

Find a Doctor

Dr Susan Hue Swee Shan

Designations:

Senior Consultant, Department of Pathology, National University Hospital
Senior Consultant, National University Cancer Institute, Singapore

Qualifications:

MBBS (Singapore), PhD (U.K.), FRCPA (Australia)

Specialties/Sub-specialties:

Pathology

Special Interests:

Haematopathology, Soft Tissue Pathology, Flow Cytometry

Make an Appointment

Contact Us:

Find Out More:

Make an Appointment

Biosketch

Dr. Susan SS Hue obtained her medical degree from the National University of Singapore (NUS) and her Ph.D from Imperial College London, U.K. in 2009. She underwent her specialty training in anatomical pathology and became a Fellow of The Royal College of Pathologists of Australasia (FRCPA) in 2015. Other than histopathology reporting, Dr. Hue also holds appointments in Department of Laboratory Medicine for flow cytometry reporting.

Journals & Publications

Hue, S. S.-S. et al. (2023). Tissue-Specific microRNA Expression Profiling to Derive Novel Biomarkers for the Diagnosis and Subtyping of Small B-Cell Lymphomas. Cancers. (2023 IF: 6.6)
Hoppe, M. M., Hue, S.S.S et al. (2023). Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma. Cancer Discov. (2023 IF 28.2)
Wah, N. W., Hue, S.S.S et al. (2023). Clinicopathologic and Molecular Characteristics of Epstein-Barr Virus–Associated Smooth Muscle Tumor Compared With Those of Leiomyoma and Leiomyosarcoma. Mod. Pathol. (2023 IF 8.2)
Hue, S.-S. S., Ng, S.-B., Wang, S., Tan, S.-Y. (2022). Cellular Origins and Pathogenesis of Gastrointestinal NK- and T-Cell Lymphoproliferative Disorders. Cancers. (2023 IF: 6.6)
Dashraath, P., Hue, S.S.S et al. (2022). Interferon shrinks spleen in pregnant patient with myeloproliferative neoplasm. The Lancet. (2023 IF: 202.731)
Tan, H. M., … Hue, S.S.S. (2022). MicroRNAs as Potential Biomarkers in the Differential Diagnosis of Lipomatous Tumors and Their Mimics. Int. J. Mol. Sci. (2023 IF 6.2)
Hue, S. S.-S., Oon, M. L., Wang, S., Tan, S.-Y., Ng, S.-B. (2021). Epstein–Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach. Pathology (Phila.). (2023 IF: 4.5)
Hue, S. et al. (2020). Terminal deoxynucleotidyl transferase negative B-lymphoblastic leukaemia/lymphoma with CD138 expression. Pathology (Phila.). (2023 IF: 4.5)
Mzoughi, S., Hue, S.S.S et al. (2020). PRDM15 is a key regulator of metabolism critical to sustain B-cell lymphomagenesis. Nat. Commun. (2023 IF: 17.69)
de Mel, S., Hue, S.S.S et al. (2019). Molecular pathogenic pathways in extranodal NK/T cell lymphoma. J. Hematol. Oncol. (2023 IF 23.17)

Professional Memberships

Fellowship of Royal College of Pathologists of Australasia

2024/05/02